NIH stops clinical trial on combination cholesterol treatment

Links shared publicly online about this topic.

  • 265
    total visits

NIH stops clinical trial on combination cholesterol treatment

medicalxpress.com

The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health has stopped a clinical trial studying a blood lipid treatment 18 months earlier than planned. The trial found that adding high dose, extended-release niacin to statin treatment in people with heart and vascular ...

View full resource at medicalxpress.com

Tags: Heart, Cholesterol, Lung, Clinical Trial, Healthy Living, National Institutes of Health, NHLBI

  • Share

Most Recently Shared on May 26, 2011 at 4:55 pm By:

physorg_health PhysOrg Health News

NIH stops clinical trial on combination cholesterol treatment http://tw.medicalxpress.com/225633244

11 months ago...

Symposier - AIM-HIGH Stopped: No Benefit of Niacin

symposier.com — “Uploaded and shared in Youtube by: ACCinTouch — Dr. Christopher Cannon provides his perspective on the news today that the NIH is stopping a clinical trial on combination cholesterol treatment. Christopher P. Cannon, MD, FACC Statements or opinions expressed in this program reflects the views of the contributors and do not reflect the official policy of the ACCF, unless otherwise noted.View full resource at symposier.com

  • View Related
  • Share

Most Recently Shared on May 31, 2011 at 3:55 pm By:

SympoCardiology Symposier Cardiology Cardiology and Health Business

AIM-HIGH (clinical trial on combination cholesterol treatment) Stopped: No Benefit of Niacin. http://bit.ly/l4FkJ7

11 months ago...

NIH stops clinical trial on combination cholesterol treatment, May 26, 2011 News Release - National Institutes of Health (NIH)

nih.gov — “The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health has stopped a clinical trial studying a blood lipid treatment 18 months earlier than planned. The trial found that adding high dose, extended-release niacin to statin treatment in people with heart and vascular disease, did not reduce the risk of cardiovascular events, including heart attacks and stroke.View full resource at nih.gov

  • View Related
  • Share

Most Recently Shared on May 26, 2011 at 6:29 pm By:

westr westr Doctor, Health Social Media, and PhD

HDL Enigma: NIH stops clinical trial on combination cholesterol treatment. http://1.usa.gov/kSfScN So much for Niaspan..

11 months ago...

Advertisement